Hot Biotech Upgrades: Zenas BioPharma and BioAge Labs Shine Bright

Wall Street analysts are bullish on Zenas BioPharma and BioAge Labs with strong upgrades, highlighting near-term FDA potential and promising drug data for big growth in 2026.